Contractor: Florida State University College of Medicine
Agency Contract Number: MED185 (formerly MED143)
Current Contract Period: 10/1/2016 – 6/30/2019
The Agency has contracted with Florida State University to conduct an independent evaluation of the Medication Therapy Management (MTM) program authorized under Florida’s section 1115 MEDS-AD Research and Demonstration Waiver approved by the Centers for Medicare and Medicaid Services.
The goals of the MTM program are to improve the quality of care and prescribing practices based on best-practice guidelines, improve patient adherence to medication plans, reduce clinical risk, and lower prescribed drug costs and the rate of inappropriate spending for certain Medicaid prescription drugs.
|Deliverable / Activity Name|
|Demonstration Year 10 (CY 2015)
MEDS-AD Waiver MTM Program Evaluation – Final Report [1.48MB]
|Demonstration Year 11 (CY2016)
MEDS-AD Waiver MTM Program Evaluation – Final Report – Due Winter 2018
|Demonstration Year 12 (CY 2017)
MEDS-AD Waiver MTM Program Evaluation – Final Report – Due Winter 2019
Agency Contact: Maurice Patterson, Contract Manager